These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12374895)

  • 1. Impaired mechanisms of leukocyte adhesion in vitro by the calcium channel antagonist mibefradil.
    Nebe B; Holzhausen C; Rychly J; Urbaszek W
    Cardiovasc Drugs Ther; 2002 May; 16(3):183-93. PubMed ID: 12374895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired mechanisms of leukocyte adhesion in vitro by the calcium channel antagonist mibefradil.
    Lijnen PJ
    Cardiovasc Drugs Ther; 2002 May; 16(3):179-80. PubMed ID: 12374893
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of lens epithelial cell adhesion by the calcium antagonist Mibefradil correlates with impaired integrin distribution and organization of the cytoskeleton.
    Beck R; Nebe B; Guthoff R; Rychly J
    Graefes Arch Clin Exp Ophthalmol; 2001 Jul; 239(6):452-8. PubMed ID: 11561795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
    Min JY; Sandmann S; Meissner A; Unger T; Simon R
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis by the calcium antagonist mibefradil correlates with depolarization of the membrane potential and decreased integrin expression in human lens epithelial cells.
    Nebe B; Kunz F; Peters A; Rychly J; Noack T; Beck R
    Graefes Arch Clin Exp Ophthalmol; 2004 Jul; 242(7):597-604. PubMed ID: 15069564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
    Baylis C; Qiu C; Engels K
    Am J Kidney Dis; 2001 Dec; 38(6):1292-7. PubMed ID: 11728963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel.
    Schmitt R; Clozel JP; Iberg N; Bühler FR
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1161-5. PubMed ID: 7627710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model.
    Griffin KA; Picken M; Bakris GL; Bidani AK
    Hypertension; 2001 May; 37(5):1268-72. PubMed ID: 11358939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca2+-agonistic effect of a T-type Ca-channel blocker mibefradil (Ro 40-5967).
    Avdonin PV; Buhler FR; Tkachuk VA
    Membr Cell Biol; 2000; 13(5):645-55. PubMed ID: 10987388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists.
    Sarsero D; Fujiwara T; Molenaar P; Angus JA
    Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic interaction between mibefradil and other calcium channel blockers.
    Matthes J; Huber I; Haaf O; Antepohl W; Striessnig J; Herzig S
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):578-83. PubMed ID: 10882031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of L- and T-type calcium channel antagonists on cardiovascular reflexes in conscious rabbits.
    Devlin MG; Angus JA; Wilson KM; Wright CE
    Clin Exp Pharmacol Physiol; 2002; 29(5-6):372-80. PubMed ID: 12010178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mibefradil is more effective than verapamil for restoring post-ischemic function of isolated hearts of guinea pigs with acute renal failure.
    Grasic Kuhar C; Budihna MV; Pleskovic RZ
    Eur J Pharmacol; 2004 Mar; 488(1-3):137-46. PubMed ID: 15044045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats.
    Wagner C; Krämer BK; Hinder M; Kieninger M; Kurtz A
    Br J Pharmacol; 1998 Jun; 124(3):579-85. PubMed ID: 9647484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart.
    Farkas A; Qureshi A; Curtis MJ
    Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-channel pharmacology of mibefradil in human native T-type and recombinant Ca(v)3.2 calcium channels.
    Michels G; Matthes J; Handrock R; Kuchinke U; Groner F; Cribbs LL; Pereverzev A; Schneider T; Perez-Reyes E; Herzig S
    Mol Pharmacol; 2002 Mar; 61(3):682-94. PubMed ID: 11854450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of adhesion molecule expression on endothelial cells by verapamil and other Ca++ channel blockers.
    Hailer NP; Blaheta RA; Harder S; Scholz M; Encke A; Markus BH
    Immunobiology; 1994 Aug; 191(1):38-51. PubMed ID: 7528721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of mibefradil on contractions induced by sympathetic neurotransmitter release in the rat tail artery.
    van der Lee R; Pfaffendorf M; De Mey JG; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):74-9. PubMed ID: 10651150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats.
    Sandmann S; Claas R; Cleutjens JP; Daemen MJ; Unger T
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):64-77. PubMed ID: 11152376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes.
    Ma G; Allen TJ; Cooper ME; Cao Z
    Kidney Int; 2004 Sep; 66(3):1090-8. PubMed ID: 15327403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.